Randomized Trial of Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: 5-Year Outcomes

Related

• 

  Comparison of Visual and Anatomic Results After Combined Boston Keratoprosthesis, Vitrectomy and Glaucoma Surgery (as Needed) to Keratoprosthesis Alone

  Jennifer I. Lim, MD, FARVO, FASRS

  Annual Meeting Talks

  2018

• 

  Complications or Are They: Why We Can NEVER Get Enough ReST

  Jeffrey S. Heier, MD

  Peter K. Kaiser, MD FASRS

  Geoffrey G. Emerson, MD, PhD, FASRS

  J. Michael Jumper, MD, FASRS

  Ehab N. ELRAYES, MD, PhD ,FASRS

  Daniel Simhaee, MD

  ASSAF DOTAN, MD

  Paul Hahn, MD, PhD, FASRS

  Philip J. Ferrone, MD, FASRS

  Annual Meeting Talks

  2018

• 

  Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Should Baseline Characteristics Affect Choice of Treatment?

  Susan B. Bressler, MD, FASRS

  Annual Meeting Talks

  2018